🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareIs there a ceiling effect for GLP-1-mediated weight loss? Page 2

Is there a ceiling effect for GLP-1-mediated weight loss?

Dr.ObesityMed Mon, Jun 8, 2026 at 5:24 AM 20 replies 213 viewsPage 2 of 4
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jun 8, 2026 at 5:47 AM#6
TirzTom said:
Relative and absolute effects need reading together.

This is where I part company with the consensus forming above. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

44 14JakeSmashed95, NauseaFreeNow, SteveThurs and 41 others
Reply Quote Save Share Report
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Jun 8, 2026 at 5:56 AM#7
Dr.ObesityMed said:
I keep finding that the number in the press summary and the number in the paper are not the same number, and the difference is always in the same…

Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals. Bayesian approaches provide probability distributions that are more intuitive for clinical decision-making.

For example: "There is a 98.5% probability that semaglutide 2.4mg produces >10% weight loss vs placebo" is more actionable than "RR 3.4, 95% CI 2.8-4.1, p<0.001."

The the trial evidence evidence is strong under both frameworks, but Bayesian analysis better communicates the degree of certainty for individual patient counseling.

43 13Dr.ObesityLA, NurseKim_ATL, paul_denver and 40 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jun 8, 2026 at 6:06 AM#8
Dr.NateNeph said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational studies can provide useful evidence.

A recent PSM study of 25,000 GLP-1 users vs matched controls showed reduced MI incidence (HR 0.78) over 5 years of follow-up[1].

These results complement the RCT data and suggest the benefits translate to real-world populations.

References:
[1] Registry-based cohort study, pre-print 2024.
42 12jennifer_SEA, tyler_CSCS, VanRx_Mike and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Jun 8, 2026 at 6:15 AM#9

One thing that is still open after TomTeleRx’s answer:

How long did you give it before you decided it was working?

41 11laura_annarbor, JenMemphis, pat_auckland and 38 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Jun 8, 2026 at 6:59 AM#10

Closing the loop on my own question.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

45 20A1cHero_PHX, Dr.RenalNash, LipidDoc_ATL and 42 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
What I wish I knew before starting GLP-1 therapy14 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register